Hello and Welcome to Patientsville.com, Your Source for all MESTINON information. We are dedicated to provide You with MESTINON safety information. Learn about MESTINON serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MESTINON Safety Reports
Total MESTINON reports: 5.MESTINON FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 4.
Take MESTINON Side Effects Survey or Share Your MESTINON Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported MESTINON problem on Feb 20, 2007. Male patient, 81 years of age, was diagnosed with myasthenia gravis, herpes zoster and was treated with MESTINON. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, condition aggravated, herpes zoster. MESTINON dosage: 60 MG; PRN. During the same period patient was treated with PREDNISONE, XOPENEX, SINGULAIR, ZOCOR, DILTIAZEM, WARFARIN, DUTASTERIDE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
MESTINON problem was reported by a Physician from UNITED KINGDOM on Mar 19, 2007. Female patient, 15 years of age, was diagnosed with myasthenia gravis and was treated with MESTINON. After drug was administered, patient experienced the following problems/side effects: acne, gastrointestinal disorder, toxic epidermal necrolysis. MESTINON dosage: 90 MG; QID; PO. During the same period patient was treated with PREDNISOLONE, MINOCIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported MESTINON problem on Sept 08, 2006. Female patient, 15 years of age, was diagnosed with myasthenia gravis and was treated with MESTINON. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. MESTINON dosage: 90 MG; QID; PO. During the same period patient was treated with PREDNISOLONE, MINOCIN MR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
MESTINON problem was reported by a Health Professional from FRANCE on Nov 03, 2006. Male patient, 69 years of age, was diagnosed with muscular weakness and was treated with MESTINON. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. MESTINON dosage: 60 MG; BID; PO. During the same period patient was treated with IMURAN, EPREX, DALTEPARIN, MEDROL, LANTUS, LASIX, TARDYFERON, DIFFU K. Patient died on 10/10/2006.
Consumer or non-health professional from FRANCE reported MESTINON problem on Aug 08, 2007. Female patient, 49 years of age, was diagnosed with psychotic disorder and was treated with MESTINON. After drug was administered, patient experienced the following problems/side effects: akathisia, anxiety, delirium, persecutory delusion. MESTINON dosage: 300 MG; QD; PO. During the same period patient was treated with ARIPIPRAZOLE, FLUVOXAMINE MALEATE, TERCIAN, MEPRONIZINE, THERALENE, TRANXENE. Patient was hospitalized. Patient recovered.